Reduced levels of miR‐590‐3p are associated with upregulation of SIRT1 followed by hyperacetylation of p53 and increased levels of BAX and p21, leading to malignant characteristics in breast cancer cells [73]. The gene discussed is SIRT1; the disease is breast cancer.